TrialBMJ open2026

Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trial.

Emi Khoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.